156 related articles for article (PubMed ID: 37842073)
41. Image-guided radiotherapy for prostate cancer using 3 different techniques: localization data of 186 patients.
Garibaldi C; Jereczek-Fossa BA; Zerini D; Cambria R; Ferrari A; Serafini F; Cattani F; Tagaste B; Fodor C; Luraschi R; Orecchia R
Tumori; 2015; 101(3):273-80. PubMed ID: 25908027
[TBL] [Abstract][Full Text] [Related]
42. Intrafraction monitoring of prostate motion during radiotherapy using the Clarity
Richardson AK; Jacobs P
Radiography (Lond); 2017 Nov; 23(4):310-313. PubMed ID: 28965894
[TBL] [Abstract][Full Text] [Related]
43. Dosimetric impact of soft-tissue based intrafraction motion from 3D cine-MR in prostate SBRT.
de Muinck Keizer DM; Kontaxis C; Kerkmeijer LGW; van der Voort van Zyp JRN; van den Berg CAT; Raaymakers BW; Lagendijk JJW; de Boer JCJ
Phys Med Biol; 2020 Jan; 65(2):025012. PubMed ID: 31842008
[TBL] [Abstract][Full Text] [Related]
44. Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy.
Case RB; Moseley DJ; Sonke JJ; Eccles CL; Dinniwell RE; Kim J; Bezjak A; Milosevic M; Brock KK; Dawson LA
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):918-25. PubMed ID: 20207501
[TBL] [Abstract][Full Text] [Related]
45. Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment.
Mutanga TF; de Boer HC; Rajan V; Dirkx ML; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):400-7. PubMed ID: 22019244
[TBL] [Abstract][Full Text] [Related]
46. Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study.
Sripadam R; Stratford J; Henry AM; Jackson A; Moore CJ; Price P
Radiother Oncol; 2009 Mar; 90(3):312-7. PubMed ID: 18783839
[TBL] [Abstract][Full Text] [Related]
47. What benefit could be derived from on-line adaptive prostate radiotherapy using rectal diameter as a predictor of motion?
Oates R; Gill S; Foroudi F; Joon ML; Schneider M; Bressel M; Kron T
J Med Phys; 2015; 40(1):18-23. PubMed ID: 26150683
[TBL] [Abstract][Full Text] [Related]
48. The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer.
Hosni A; Rosewall T; Craig T; Kong V; Bayley A; Berlin A; Bristow R; Catton C; Warde P; Chung P
Radiat Oncol; 2017 Mar; 12(1):50. PubMed ID: 28279179
[TBL] [Abstract][Full Text] [Related]
49. Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging.
Foroudi F; Pham D; Bressel M; Gill S; Kron T
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):77-82. PubMed ID: 23332382
[TBL] [Abstract][Full Text] [Related]
50. An endorectal balloon reduces intrafraction prostate motion during radiotherapy.
Smeenk RJ; Louwe RJ; Langen KM; Shah AP; Kupelian PA; van Lin EN; Kaanders JH
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):661-9. PubMed ID: 22099035
[TBL] [Abstract][Full Text] [Related]
51. Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
Tøndel H; Lund JÅ; Lydersen S; Wanderås AD; Aksnessæther B; Jensen CA; Kaasa S; Solberg A
Radiother Oncol; 2018 Feb; 126(2):229-235. PubMed ID: 29398152
[TBL] [Abstract][Full Text] [Related]
52. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac.
Eijkelenkamp H; Boekhoff MR; Verweij ME; Peters FP; Meijer GJ; Intven MPW
Radiother Oncol; 2021 Sep; 162():150-155. PubMed ID: 34280404
[TBL] [Abstract][Full Text] [Related]
53. Intrafraction prostate motion during IMRT for prostate cancer.
Huang E; Dong L; Chandra A; Kuban DA; Rosen II; Evans A; Pollack A
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):261-8. PubMed ID: 12023128
[TBL] [Abstract][Full Text] [Related]
54. Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?
Drabble J; Das P; George B; Camilleri P; Morris A
Med Dosim; 2022 Winter; 47(4):334-341. PubMed ID: 35907693
[TBL] [Abstract][Full Text] [Related]
55. Intrafraction motion during CyberKnife® prostate SBRT: impact of imaging frequency and patient factors.
Rose C; Ebert MA; Mukwada G; Skorska M; Gill S
Phys Eng Sci Med; 2023 Jun; 46(2):669-685. PubMed ID: 36971949
[TBL] [Abstract][Full Text] [Related]
56. Assessment of intrafraction motion for spine and non-spine bone metastases treated with image-guided stereotactic body radiotherapy without 6 degrees-of-freedom couch correction.
Cereno RE; Bartlett Q; Lamey M; Hyde D; Mou B
J Radiosurg SBRT; 2022; 8(4):313-319. PubMed ID: 37416334
[TBL] [Abstract][Full Text] [Related]
57. SU-E-J-124: Assessment of Intrafraction and Interfraction Motion in Cranial SRT Using Tomotherapy.
Barbee D; Rasmussen K; Bartlett R
Med Phys; 2012 Jun; 39(6Part8):3681. PubMed ID: 28518935
[TBL] [Abstract][Full Text] [Related]
58. Use of surface-guided radiation therapy in combination with IGRT for setup and intrafraction motion monitoring during stereotactic body radiation therapy treatments of the lung and abdomen.
Heinzerling JH; Hampton CJ; Robinson M; Bright M; Moeller BJ; Ruiz J; Prabhu R; Burri SH; Foster RD
J Appl Clin Med Phys; 2020 May; 21(5):48-55. PubMed ID: 32196944
[TBL] [Abstract][Full Text] [Related]
59. Intrafraction Motion Management of Renal Cell Carcinoma With Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy.
Prins FM; Stemkens B; Kerkmeijer LGW; Barendrecht MM; de Boer HJ; Vonken EPA; Lagendijk JJW; Tijssen RHN
Pract Radiat Oncol; 2019 Jan; 9(1):e55-e61. PubMed ID: 30261329
[TBL] [Abstract][Full Text] [Related]
60. Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes.
Ingrosso G; Miceli R; Ponti E; Lancia A; di Cristino D; de Pasquale F; Bove P; Santoni R
J Cancer Res Ther; 2019 Mar; 15(Supplement):S69-S75. PubMed ID: 30900624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
